Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Recruiting
Observational Study
Cardiovascular Diseases (CVD)
Type 2 Diabetes
Chronic Respiratory Diseases
Obesity (Disorder)
Chronic Kidney Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 69
- Sex
- Any
- Study type
- Observational
- Participants needed
- 6,720 (estimated)
- Sponsor
- Asfendiyarov Kazakh National Medical University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 to 69 years.
* Residents of 17 regions of Kazakhstan.
* Willingness to participate and provide informed consent.
Exclusion Criteria:
* Age less than 18 years old or over 69 years old.
* Failure to provide informed consent or incomplete participation in data co…
Contacts